Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels.

Bustillo J, Wolff C, Myers-y-Gutierrez A, Dettmer TS, Cooper TB, Allan A, Lauriello J, Valenzuela CF.

Schizophr Res. 2004 Jan 1;66(1):31-9.

PMID:
14693350
2.

Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels.

Bustillo J, Barrow R, Paz R, Tang J, Seraji-Bozorgzad N, Moore GJ, Bolognani F, Lauriello J, Perrone-Bizzozero N, Galloway MP.

Neuropsychopharmacology. 2006 Apr;31(4):751-6.

3.

Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol.

Harte MK, Bachus SB, Reynolds GP.

Schizophr Res. 2005 Jun 15;75(2-3):303-8. Epub 2004 Dec 1.

PMID:
15885521
4.

Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.

Bustillo JR, Rowland LM, Jung R, Brooks WM, Qualls C, Hammond R, Hart B, Lauriello J.

Neuropsychopharmacology. 2008 Sep;33(10):2456-66. Epub 2007 Dec 19.

5.

Long term antipsychotic treatment does not alter metabolite concentrations in rat striatum: an in vivo magnetic resonance spectroscopy study.

Lindquist DM, Dunn RS, Cecil KM.

Schizophr Res. 2011 May;128(1-3):83-90. doi: 10.1016/j.schres.2011.02.019. Epub 2011 Mar 22.

6.

Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo.

Lindquist DM, Hawk RM, Karson CN, Komoroski RA.

Magn Reson Med. 2000 Mar;43(3):355-8.

7.

Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells.

Arun P, Madhavarao CN, Moffett JR, Namboodiri AM.

J Neurochem. 2008 Aug;106(4):1669-80. doi: 10.1111/j.1471-4159.2008.05524.x. Epub 2008 Jun 28.

8.

N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.

Szulc A, Galińska B, Tarasów E, Kubas B, Dzienis W, Konarzewska B, Poplawska R, Tomczak AA, Czernikiewicz A, Walecki J.

Med Sci Monit. 2007 May;13 Suppl 1:17-22.

PMID:
17507880
9.

Effects of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain.

Frederick JA, Meador-Woodruff JH.

Schizophr Res. 1999 Jul 27;38(1):7-12.

PMID:
10427606
10.

Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia.

Bustillo JR, Lauriello J, Rowland LM, Jung RE, Petropoulos H, Hart BL, Blanchard J, Keith SJ, Brooks WM.

Psychiatry Res. 2001 Oct 1;107(3):135-49.

PMID:
11566430
12.

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

Duncan GE, Leipzig JN, Mailman RB, Lieberman JA.

Brain Res. 1998 Nov 23;812(1-2):65-75.

PMID:
9813244
14.

Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats.

Levant B, Crane JF, Carlson SE.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):728-32. Epub 2006 Jan 24.

PMID:
16442197
15.

Alterations in NMDA receptor subunit levels in the brain regions of rats chronically administered typical or atypical antipsychotic drugs.

Hanaoka T, Toyoda H, Mizuno T, Kikuyama H, Morimoto K, Takahata R, Matsumura H, Yoneda H.

Neurochem Res. 2003 Jun;28(6):919-24.

PMID:
12718446
17.

Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats.

Spurney CF, Baca SM, Murray AM, Jaskiw GE, Kleinman JE, Hyde TM.

Synapse. 1999 Dec 15;34(4):266-76.

PMID:
10529721
18.

Comparative analysis of acute and chronic administration of haloperidol and clozapine using [3H] 2-deoxyglucose metabolic mapping.

Wotanis J, Hanak SE, Wettstein JG, Black MD.

Schizophr Res. 2003 Jun 1;61(2-3):195-205.

PMID:
12729871
19.

Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss.

Roe DL, Bardgett ME, Csernansky CA, Csernansky JG.

Psychopharmacology (Berl). 1998 Jul;138(2):151-8.

PMID:
9718284

Supplemental Content

Support Center